ClinicalTrialsFinder

Biallelic RPE65 Mutation-associated Retinal Dystrophy Clinical Trials in Beijing, Beijing Municipality

1 recruitingBeijing, Beijing Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Biallelic RPE65 Mutation-associated Retinal Dystrophy
Frontera Therapeutics9 enrolled1 locationNCT05858983